Literature DB >> 21953130

Indications for staging laparoscopy in clinical T4M0 gastric cancer.

Kazuhito Tsuchida1, Takaki Yoshikawa, Akira Tsuburaya, Haruhiko Cho, Osamu Kobayashi.   

Abstract

BACKGROUND: This study was undertaken to determine the efficacy of the clinical indications for performing staging laparoscopy for locally advanced gastric cancer to detect peritoneal metastasis or positive cytology findings.
METHODS: The study included 231 patients with T4 gastric cancer without hematogenous or clinically evident peritoneal metastasis. The clinicopathologic features, including T and N factors, were diagnosed by clinical staging. The relation between the clinicopathologic features and the presence of peritoneal metastasis or lavage cytology at surgery was analyzed.
RESULTS: A total of 31 patients underwent staging laparoscopy; 200 others underwent open surgery as a primary treatment. Both peritoneal metastasis and lavage cytology were negative in 145 (62.8%) patients, whereas peritoneal metastasis or lavage cytology was positive in 86 patients (37.2%). When calculating diagnostic accuracy in the 23 patients who underwent open laparotomy after staging laparoscopy, the accuracy rate was 95.7%. A multivariate analysis showed that a tumor location involving three portions; macroscopic type 3, 4, or 5; and positive lymph node metastasis to all three is significantly correlated with either peritoneal metastasis or positive cytology. When patients had two or three factors among these three independent risk factors, peritoneal metastasis or positive cytology could be detected with 91.9% sensitivity and 46.7% positive predictive value.
CONCLUSIONS: The selection of T4 tumors based on clinically evaluable risk factors is therefore considered useful for detecting peritoneal metastasis efficiently and hence avoiding unnecessary staging laparoscopy.

Entities:  

Mesh:

Year:  2011        PMID: 21953130     DOI: 10.1007/s00268-011-1290-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis.

Authors:  T Tanaka; K Kumagai; K Shimizu; K Masuo; K Yamagata
Journal:  J Surg Oncol       Date:  2000-11       Impact factor: 3.454

2.  Prognostic significance of the cytologic features of free cancer cells in the peritoneal cavity of patients with gastric cancer.

Authors:  Takashi Majima; Takashi Ichikura; Hidetaka Mochizuki
Journal:  Surg Today       Date:  2002       Impact factor: 2.549

3.  Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma.

Authors:  B Nakata; K Hirakawa-YS Chung; Y Kato; Y Yamashita; K Maeda; N Onoda; T Sawada; M Sowa
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

Review 4.  Epidemiology of gastric cancer in Japan.

Authors:  M Inoue; S Tsugane
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer.

Authors:  D A Stell; C R Carter; I Stewart; J R Anderson
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

7.  Diagnostic usefulness of carbohydrate antigen-125 in cancerous and noncancerous peritoneal effusions.

Authors:  Türker Kemer; Murat Ormen; Filiz Kuralay; Mustafa Pehlivan; Belkis Unsal; Ethem Tankurt
Journal:  Tohoku J Exp Med       Date:  2005-01       Impact factor: 1.848

8.  The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.

Authors:  David Bentrem; Andrew Wilton; Madhu Mazumdar; Murray Brennan; Daniel Coit
Journal:  Ann Surg Oncol       Date:  2005-03-31       Impact factor: 5.344

9.  Peritoneal cytology in patients with gastric cancer exposed to the serosa--a proposed new classification based on the local and distant cytology.

Authors:  Takaki Yoshikawa; Akira Tsuburaya; Osamu Kobayashi; Motonori Sairenji; Hisahiko Motohashi; Yoshikazu Noguchi
Journal:  Hepatogastroenterology       Date:  2003 Jul-Aug

10.  Has there been any improvement in the staging of gastric cancer? Findings from the German Gastric Cancer TNM Study Group.

Authors:  H Rohde; B Gebbensleben; P Bauer; H Stützer; J Zieschang
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

View more
  12 in total

1.  Staging laparoscopy improves treatment decision-making for advanced gastric cancer.

Authors:  Yan-Feng Hu; Zhen-Wei Deng; Hao Liu; Ting-Yu Mou; Tao Chen; Xin Lu; Da Wang; Jiang Yu; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

2.  Application of laparoscopy in the diagnosis and treatment of gastric cancer.

Authors:  Ziyu Li; Jiafu Ji
Journal:  Ann Transl Med       Date:  2015-06

3.  Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Authors:  Masanori Tokunaga; Masanori Terashima; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Hirofumi Yasui; Narikazu Boku
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

4.  Conversion Surgery for Gastric Cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy.

Authors:  Masaki Nakamura; Toshiyasu Ojima; Mikihito Nakamori; Masahiro Katsuda; Toshiaki Tsuji; Keiji Hayata; Tomoya Kato; Hiroki Yamaue
Journal:  J Gastrointest Surg       Date:  2018-09-27       Impact factor: 3.452

5.  Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis.

Authors:  Ziyu Li; Zhemin Li; Shuqin Jia; Zhaode Bu; Lianhai Zhang; Xiaojiang Wu; Shuangxi Li; Fei Shan; Xin Ji; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2017-04       Impact factor: 5.087

6.  Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors.

Authors:  Hisahiro Hosogi; Hisashi Shinohara; Shigeru Tsunoda; Shigeo Hisamori; Hitoshi Sumida; Koya Hida; Kazutaka Obama; Hiroshi Okabe; Yoshiharu Sakai
Journal:  Langenbecks Arch Surg       Date:  2016-11-29       Impact factor: 3.445

7.  Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases.

Authors:  Masahide Ikeguchi; Kozo Miyatani; Seigo Takaya; Tomoyuki Matsunaga; Youji Fukumoto; Tomohiro Osaki; Hiroaki Saito; Toshiro Wakatsuki
Journal:  Indian J Surg Oncol       Date:  2015-07-01

8.  Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.

Authors:  Sumiya Ishigami; Yoshikazu Uenosono; Takaaki Arigami; Shigehiro Yanagita; Hiroshi Okumura; Yasuto Uchikado; Yoshiaki Kita; Hiroshi Kurahara; Yuko Kijima; Akihiro Nakajo; Kosei Maemura; Shoji Natsugoe
Journal:  World J Surg Oncol       Date:  2014-11-18       Impact factor: 2.754

9.  "Four-Step Procedure" of laparoscopic exploration for gastric cancer in West China Hospital: a retrospective observational analysis from a high-volume institution in China.

Authors:  Kai Liu; Xin-Zu Chen; Wei-Han Zhang; Dong-Yang Zhang; Yi Luo; Yue Yu; Kun Yang; Shi-Jie Yang; Xiao-Long Chen; Li-Fei Sun; Lin-Yong Zhao; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Surg Endosc       Date:  2018-11-26       Impact factor: 4.584

10.  Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.

Authors:  Biao Fan; Zhaode Bu; Ji Zhang; Xianglong Zong; Xin Ji; Tao Fu; Ziyu Jia; Yinan Zhang; Xiaojiang Wu
Journal:  BMC Cancer       Date:  2021-03-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.